Keyphrases
Prostate Cancer
95%
Androgen Receptor
82%
Bladder Cancer
72%
Antiandrogen
43%
Androgen Signaling
38%
Muscle-invasive Bladder Cancer
36%
Radical Cystectomy
36%
Advanced Prostate Cancer
36%
Castration-resistant Prostate Cancer
34%
Human Immunodeficiency Virus Type 1 (HIV-1)
34%
Tumor DNA
28%
Curative Intent
25%
PAK2
24%
Minimal Residual Disease
24%
DNA Detection
24%
Overall Survival
23%
Upper Tract Urothelial Carcinoma
21%
Tumor
20%
Immune Checkpoint Blockade
19%
National Cancer Database
18%
Glucocorticoid Receptor
18%
Virus
18%
Enzalutamide
18%
Androgen Deprivation Therapy
17%
Second-generation Antiandrogens
16%
Mouse Model
16%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
16%
DNA Repair
15%
Androgen Receptor Antagonist
15%
MDV3100
15%
Androgen Receptor Blockade
14%
Survival Outcomes
14%
Resistance Mechanisms
14%
Metastatic Urothelial Carcinoma
14%
Urothelial
13%
KDM6A
13%
Urothelial Carcinoma
13%
Chemotherapy
13%
Squamous Cell Carcinoma of the Bladder
12%
Merlin
12%
Definitive Concurrent Chemoradiotherapy
12%
Endothelial Cells
12%
Urothelial Tumors
12%
Bladder Tumor
12%
Systemic Chemotherapy
12%
Local Radiation Therapy
12%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
12%
Metastatic Urothelial Cancer
12%
Tumor Survival
12%
Muscle-invasive
12%
Medicine and Dentistry
Prostate Cancer
100%
Bladder Cancer
70%
Androgen Receptor
54%
Neoplasm
52%
Muscle Invasive Bladder Cancer
36%
Cystectomy
36%
Antiandrogen
36%
Malignant Neoplasm
30%
Transitional Cell Carcinoma
29%
Bladder
28%
Radiation Therapy
27%
Cohort Analysis
26%
Overall Survival
25%
Minimal Residual Disease
24%
Chemoradiotherapy
24%
Castration Resistant Prostate Cancer
20%
Bladder Tumor
19%
Enzalutamide
19%
Immune Checkpoint Blockade
18%
Organoid
15%
Enhancer Region
13%
Therapy Delay
12%
Palbociclib
12%
Urothelial Cancer
12%
4 Iodo 2,5 Dimethoxyamphetamine
12%
CTLA-4
12%
Androgen Deprivation Therapy
12%
Brain Metastasis
12%
Squamous Cell Carcinoma
12%
Arm
12%
Transcriptomics
12%
Endothelial Cell
12%
Peroxisome Proliferator Activated Receptor
12%
Glucocorticoid Receptor
12%
Drive
12%
Diseases
11%
Somatics
11%
Tumor Cell
8%
Transurethral Resection
7%
Androgen
7%
Biopsy Technique
6%
T-Helper Cell
6%
Small-Cell Carcinoma
6%
Genome-Wide Analysis of Gene Expression
6%
Prostate Specific Antigen
5%
Receptor Expression
5%
Cancer Model
5%
Treatment Response
5%
Biochemistry, Genetics and Molecular Biology
Androgen Receptor
76%
Genomics
38%
Enzalutamide
31%
Silent Mutation
24%
Cohort Study
24%
Immune Checkpoints
24%
Normal Human
24%
DNA Analysis
24%
Exome Sequencing
24%
DNA Repair
24%
Glucocorticoid Receptor
24%
Genetics
24%
Tumor Suppressor Protein
19%
FOXA1
19%
TMPRSS2
18%
Mouse Model
16%
Human Immunodeficiency Virus
14%
Cancer Model
14%
Cell Proliferation
14%
Receptor Blocking
13%
Enhancer Region
13%
CD4
13%
Transcriptomics
12%
Overall Survival
12%
2,5-Dimethoxy-4-iodoamphetamine
12%
Allele
12%
Epigenetics
12%
Progression Free Survival
12%
Single-Nucleotide Polymorphism
12%
DNA Damage Response
12%
CTLA-4
12%
Next Generation Sequencing
12%
Solution and Solubility
12%
P21-Activated Kinases
12%
Germ Cell
12%
Germline
12%
Deep Sequencing
12%
Human Immunodeficiency Virus Type 1 Subtype B
12%
Drive
12%
CHD1
12%
Nematode
12%
Caenorhabditis Elegans
12%
Guanylate Cyclase
12%
PIK3R1
12%
Peroxisome Proliferator-Activated Receptor
12%
Human Immunodeficiency Virus 1
12%
SPOP
12%
P53
12%
Gene Dosage
12%
Cyclic Guanosine Monophosphate
12%